Screening SMAD1,SMAD2, SMAD3, andSMAD5 for germline mutations in juvenile polyposis syndrome
Data up to Jan 2025
Total Citations Per Year
Abstract
References (12)
Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling
1997 • 1,774 citations
Smad6 inhibits signalling by the TGF-β superfamily
1997 • 1,026 citations
TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4
1997 • 1,023 citations
Mutations in the SMAD4/DPC4 Gene in Juvenile Polyposis
1998 • 901 citations
MADR2 Maps to 18q21 and Encodes a TGFβ–Regulated MAD–Related Protein That Is Functionally Mutated in Colorectal Carcinoma
1996 • 855 citations
Smad3 Mutant Mice Develop Metastatic Colorectal Cancer
1998 • 677 citations
Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers
1996 • 614 citations
A transforming growth factor beta receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability.
1995 • 445 citations
Phosphorylation of Ser465 and Ser467 in the C Terminus of Smad2 Mediates Interaction with Smad4 and Is Required for Transforming Growth Factor-β Signaling
1997 • 383 citations
Mutations increasing autoinhibition inactivate tumour suppressors Smad2 and Smad4
1997 • 365 citations
Smad1 and Smad5 Act Downstream of Intracellular Signalings of BMP-2 That Inhibits Myogenic Differentiation and Induces Osteoblast Differentiation in C2C12 Myoblasts
1997 • 224 citations
Mutations in DPC4 (SMAD4) cause juvenile polyposis syndrome, but only account for a minority of cases
1998 • 144 citations